Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Non-Metastatic Prostate Cancer with Rising PSA
NCT00148772Phase 2Completed
- Sponsor
- Endeavor Health
- Start
- Aug 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in prostate cancer (PCa), sponsored by Endeavor Health. Started Aug 2005; status: completed.
02
Drugs
erlotinib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00148772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148772.